Inject
Once weekly
GLP-1 + GIP
Zepbound KwikPen
Weekly tirzepatide in the commercial Zepbound pen — weigh your appetite goals, prior GLP-1 use, and dose tolerance before you start.
One pen = four weekly dosesWeekly tirzepatide injectionSix strengths, 2.5–15 mgRx only
Start your online visitfrom$573.99/mo$558.99/moSave $15
FSA & HSA eligibleUse eligible benefit funds
Split your payment into interest-free installments with Klarna at checkout.
Private questionnaire first
Charged today — ships if prescribed
Dose rhythm
Consistent, once weekly.
One pen. Four doses. Build a rhythm you can stick with.
Stay on track
Same day each week — four doses per pen
Watch tolerance
Nausea and GI side effects peak early
Keep going
Refill timing planned
The science
Appetite gets biological.
Tirzepatide activates GLP-1 and GIP receptors involved in appetite, fullness, and metabolic signals. The online visit checks whether that mechanism makes sense for your history.
Start with history
Before shipment
Dose changes start with history.
A commercial pen does not make dose escalation automatic. Provider review checks the details that affect strength, timing, side effects, and refill planning.
Current medicationsBlood-sugar historyPrior GLP-1 useSide-effect toleranceDose-change requestsContraindications
What's inside
A multi-dose pen, not a DIY ladder.
Zepbound KwikPen is a single-patient-use prefilled multi-dose pen. Each pen is designed for four fixed weekly doses in one of six strengths, 2.5 mg to 15 mg.
2.5 mg5 mg7.5 mg10 mg12.5 mg15 mg
Clinical proof
Trial data,
not a promise
Zepbound 15 mg was studied for 72 weeks alongside reduced-calorie diet and increased physical activity; trial averages do not guarantee individual results.
Trial timeline
72 weeksAverage weight change reported in SURMOUNT-1 accumulated across 72 weeks at 15 mg — exact figures are in the references below.
Label dose ladder
2.5 mg5 mg7.5 mg10 mg12.5 mg15 mg
Dose changes follow prescribing instructions, response, and tolerance.
72 weeks
SURMOUNT trial conditions included diet and activity changes.
Up to 22.5%
Highest average weight change reported in SURMOUNT-1 at 15 mg — analysis details in the references.
Waist measurement
SURMOUNT trials also tracked waist-size change.
History before dose
Medications, side effects, blood-sugar history, and prior GLP-1 use shape the dose decision.
Medication historyContraindicationsToleranceDose and refill help
Study types include
Randomized controlled trialsLarge sample sizesGlobal populationsMultiple endpointsPeer-reviewed
Important safety information
Review GLP‑1 risks before starting Zepbound.
Boxed warning, contraindications, serious side effects, medication history, pregnancy, breastfeeding, gallbladder, pancreas, kidney, and anesthesia considerations can all change whether GLP-1 care should move forward.
Start your online visit
Share your GLP-1 history, current medications, side-effect risk, and appetite goals so a provider can decide whether to prescribe Zepbound KwikPen.
Online visitfrom$573.99$558.99/moSave $15Split your payment into interest-free installments with Klarna at checkout.
What the visit covers